These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 23681557

  • 1. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S.
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [Abstract] [Full Text] [Related]

  • 2. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA, Mohammedi K, Bellili-Muñoz N, Driss F, Sanchez M, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G.
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [Abstract] [Full Text] [Related]

  • 3. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
    Craig DW, Millis MP, DiStefano JK.
    Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
    [Abstract] [Full Text] [Related]

  • 4. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M, Ma J, Keaton JM, Dimitrov L, Mudgal P, Stromberg M, Bonomo JA, Hicks PJ, Freedman BI, Bowden DW, Ng MC.
    Hum Genet; 2016 Nov; 135(11):1251-1262. PubMed ID: 27461219
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY, Chen LS, Zhang LC, Zhou TB.
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [Abstract] [Full Text] [Related]

  • 6. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D, Ma J, Brismar K, Efendic S, Gu HF.
    J Diabetes Complications; 2009 Jul; 23(4):265-72. PubMed ID: 18599322
    [Abstract] [Full Text] [Related]

  • 7. INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathy.
    Hyvönen ME, Ihalmo P, Forsblom C, Thorn L, Sandholm N, Lehtonen S, Groop PH.
    Diabet Med; 2012 Dec; 29(12):1589-95. PubMed ID: 22486725
    [Abstract] [Full Text] [Related]

  • 8. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS, Hamdy SM.
    Ren Fail; 2011 Dec; 33(9):878-84. PubMed ID: 21854353
    [Abstract] [Full Text] [Related]

  • 9. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
    McKnight AJ, Maxwell AP, Patterson CC, Brady HR, Savage DA.
    J Diabetes Complications; 2007 Dec; 21(4):242-5. PubMed ID: 17616354
    [Abstract] [Full Text] [Related]

  • 10. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.
    Fagerholm E, Ahlqvist E, Forsblom C, Sandholm N, Syreeni A, Parkkonen M, McKnight AJ, Tarnow L, Maxwell AP, Parving HH, Groop L, Groop PH, FinnDiane Study Group.
    Diabetologia; 2012 Sep; 55(9):2386-93. PubMed ID: 22643932
    [Abstract] [Full Text] [Related]

  • 11. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.
    Savage DA, Patterson CC, Deloukas P, Whittaker P, McKnight AJ, Morrison J, Boulton AJ, Demaine AG, Marshall SM, Millward BA, Thomas SM, Viberti GC, Walker JD, Sadlier D, Maxwell AP, Bain SC.
    Diabetologia; 2008 Nov; 51(11):1998-2002. PubMed ID: 18773191
    [Abstract] [Full Text] [Related]

  • 12. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC, Tam CH, Wang Y, Luk AO, Hu C, Yang X, Lam V, Chan AW, Ho JS, Chow CC, Tong PC, Jia W, Ng MC, So WY, Chan JC.
    JAMA; 2010 Aug 25; 304(8):881-9. PubMed ID: 20736472
    [Abstract] [Full Text] [Related]

  • 13. Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.
    Ma J, Guan M, Bowden DW, Ng MCY, Hicks PJ, Lea JP, Ma L, Gao C, Palmer ND, Freedman BI.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):1034-1043. PubMed ID: 27197912
    [Abstract] [Full Text] [Related]

  • 14. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ, Savage DA, Patterson CC, Sadlier D, Maxwell AP.
    BMC Med Genet; 2007 Feb 23; 8():5. PubMed ID: 17319955
    [Abstract] [Full Text] [Related]

  • 15. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.
    Arch Mal Coeur Vaiss; 2002 Feb 23; 95(7-8):701-8. PubMed ID: 12365083
    [Abstract] [Full Text] [Related]

  • 16. Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus.
    McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP, Warren 3/UK GoKinD Study Group.
    Diabetologia; 2009 May 23; 52(5):844-9. PubMed ID: 19247629
    [Abstract] [Full Text] [Related]

  • 17. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.
    Clin Nephrol; 1999 Mar 23; 51(3):133-40. PubMed ID: 10099885
    [Abstract] [Full Text] [Related]

  • 18. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM, Cimponeriu D, Cruce M, Ion DA, Moţa E, Moţa M, Serafinceanu C, Chivu LI, Panduru M, Chivu RD, Covic AC.
    Rom J Morphol Embryol; 2010 Mar 23; 51(1):37-41. PubMed ID: 20191117
    [Abstract] [Full Text] [Related]

  • 19. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.
    Sallinen R, Kaunisto MA, Forsblom C, Thomas M, Fagerudd J, Pettersson-Fernholm K, Groop PH, Wessman M, Finnish Diabetic Nephropathy Study Group.
    Ann Med; 2010 May 06; 42(4):296-304. PubMed ID: 20429798
    [Abstract] [Full Text] [Related]

  • 20. A genome-wide association study for diabetic nephropathy genes in African Americans.
    McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MC, Sale MM, Divers J, Langefeld CD, Freedman BI, Bowden DW.
    Kidney Int; 2011 Mar 06; 79(5):563-72. PubMed ID: 21150874
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.